Myriad Genetics (MYGN): FQ4 EPS of $0.54 may not be comparable to consensus of $0.33. Revenue of...

|About: Myriad Genetics, Inc. (MYGN)|By:, SA News Editor
Myriad Genetics (MYGN): FQ4 EPS of $0.54 may not be comparable to consensus of $0.33. Revenue of $93.9M (+9%) vs. $93.5M. Shares +1.4% AH. (PR)